Key Takeaways
- In 2022, approximately 39.0 million people were living with HIV globally, including 1.4 million children aged 0-14 years.
- An estimated 1.3 million people acquired HIV in 2022, marking a 22% decline from 2010 levels.
- Globally, 630,000 people died from AIDS-related illnesses in 2022, down 69% since the peak in 2004.
- In 2022, 1.5 million people in Eastern and Southern Africa were living with HIV, the highest regional burden.
- Western and Central Africa had 5.1 million people living with HIV in 2022.
- In Asia and the Pacific, 6.7 million people were living with HIV in 2022.
- Globally, young women aged 15-24 accounted for 26% of new HIV infections in 2022 despite being only 10% of the population.
- Adolescent girls and young women aged 15-24 in Eastern and Southern Africa face 3.3 times higher HIV risk than young men.
- In 2022, 38 million adults aged 15+ were living with HIV globally.
- Heterosexual transmission accounted for 72% of new HIV infections among adults in 2022 globally.
- In Eastern and Southern Africa, 80% of new infections were through sex between men and women in 2022.
- Sex between men accounted for 21% of new HIV infections globally in 2022.
- Condom use during sex with non-regular partners reached 70% in high HIV burden countries in 2022.
- Voluntary medical male circumcision averted an estimated 3.5 million new HIV infections in 15 countries since 2010.
- PrEP use prevented 74,000 new infections globally in 2022.
While progress has been made against HIV, key populations still face a disproportionately high infection risk.
Demographic Breakdowns
- Globally, young women aged 15-24 accounted for 26% of new HIV infections in 2022 despite being only 10% of the population.
- Adolescent girls and young women aged 15-24 in Eastern and Southern Africa face 3.3 times higher HIV risk than young men.
- In 2022, 38 million adults aged 15+ were living with HIV globally.
- Children aged 0-14 represent 3.6% of all people living with HIV globally in 2022.
- Globally, 4 in 10 new HIV infections in 2022 were among young people aged 15-24.
- Women and girls accounted for 53.6% of people living with HIV aged 15+ in 2022.
- In the US, Black/African American people represented 40% of new HIV diagnoses in 2021 despite being 12% of the population.
- Hispanic/Latino people accounted for 29% of new HIV diagnoses in the US in 2021.
- Gay and bisexual men accounted for 67% of new HIV diagnoses in the US in 2021.
- Globally, people who inject drugs represent 12% of new HIV infections in 2022.
- Sex workers accounted for 12% of new HIV infections globally despite being less than 1% of the adult population in 2022.
- Transgender people are 15 times more likely to acquire HIV than the general adult population globally.
- In 2022, 73% of all children living with HIV were accessing ART globally.
- Globally, 89% of pregnant women living with HIV accessed ART in 2022 to prevent mother-to-child transmission.
- Globally, young women (15-24) accounted for 25% of new HIV infections among adults in 2023.
- 1.4 million children (0-14) were living with HIV globally in 2023.
- In sub-Saharan Africa, girls aged 15-19 are 4 times more likely to be living with HIV than boys.
- Black/African Americans accounted for 40.1% of HIV diagnoses in the US in 2022.
- Hispanic/Latino people were 32.7% of new HIV diagnoses in large US cities in 2022.
- Males accounted for 80.6% of new HIV diagnoses in the US in 2022.
- Gay/bisexual men were 65% of new HIV diagnoses in the US in 2022.
- People aged 13-24 accounted for 19% of new HIV diagnoses in the US in 2022.
- Transgender women had an HIV prevalence of 14% in the US in recent surveys.
- Globally, sex workers are 30 times more at risk of HIV infection.
- People who inject drugs have 22 times higher HIV risk globally.
- Prison populations have 3 times higher HIV prevalence than general population.
- Globally, 71% [66–76%] of all children living with HIV were on ART in 2023.
Demographic Breakdowns Interpretation
Global Statistics
- In 2022, approximately 39.0 million people were living with HIV globally, including 1.4 million children aged 0-14 years.
- An estimated 1.3 million people acquired HIV in 2022, marking a 22% decline from 2010 levels.
- Globally, 630,000 people died from AIDS-related illnesses in 2022, down 69% since the peak in 2004.
- 86% of all people living with HIV knew their HIV status in 2022 worldwide.
- Among those who knew their status, 76% were accessing antiretroviral therapy (ART) globally in 2022.
- 29.8 million people were accessing ART in 2022 out of 39 million living with HIV globally.
- HIV prevalence among adults aged 15-49 was 0.8% globally in 2022.
- Women accounted for 53% of all people living with HIV globally in 2022.
- Key populations including sex workers, gay men, transgender people, people who inject drugs, and prisoners represent only 0.4% of the global population but account for 47% of new HIV infections.
- In 2022, an estimated 1.30 million [1.13–1.50 million] individuals worldwide acquired HIV.
- The number of people living with HIV globally in 2022 was 39.0 million [37.6–40.6 million].
- AIDS-related deaths in 2022 numbered 630 000 [530 000–740 000] globally.
- 86% [83–89%] of all people living with HIV knew their HIV status in 2022.
- 76% [73–79%] of all people living with HIV were accessing treatment in 2022.
- 72% [68–75%] of all people living with HIV had suppressed viral loads in 2022.
- HIV prevalence in adults (aged 15-49 years) was 0.8% globally in 2022.
- Females aged 15+ represented 53% of adults living with HIV in 2022 globally.
- An estimated 1.3 million people acquired HIV in 2023 globally.
- 39.9 million [36.8 million–44.0 million] people were living with HIV at the end of 2023 globally.
- In 2021, 36.3 million people were living with HIV globally per WHO estimates.
Global Statistics Interpretation
Mortality and Socioeconomic Impact
- Global AIDS-related deaths have fallen by 69% since the 2004 peak of 2.1 million.
- New HIV infections dropped 59% from the 1995 peak of 3.3 million to 1.3 million in 2022.
- Without accelerated action, 34 million AIDS-related deaths are projected between 2023-2050.
- AIDS-related illnesses caused 40.4 million deaths globally since the epidemic began.
- In 2022, children accounted for 8.2% of AIDS-related deaths globally.
- Sub-Saharan Africa saw 400,000 AIDS-related deaths in 2022, 64% of the global total.
- HIV is the leading cause of death among women aged 15-49 globally.
- In South Africa, HIV contributed to 17% of all deaths in 2022.
- Globally, HIV stigma affects 1 in 3 people living with HIV, hindering treatment access.
- Economic cost of HIV in low- and middle-income countries is estimated at $1 trillion cumulatively.
- Orphans due to AIDS numbered 15.2 million children globally in 2022.
- In 2022, 9.3 million people living with HIV were not on ART, at risk of death and transmission.
- TB remains the leading cause of death among people living with HIV, killing 167,000 in 2022.
- Globally, AIDS deaths were 630,000 in 2023, down 69% from 2004 peak.
- 14 million AIDS deaths averted since 2000 due to ART scale-up.
- TB caused 167,000 deaths among PLHIV in 2023.
- Children under 10 had 90,000 AIDS deaths in 2023.
- In sub-Saharan Africa, HIV remains top killer for ages 15-44.
- Stigma and discrimination affect 1 in 5 PLHIV accessing services.
- 15.5 million children orphaned by AIDS in 2023 globally.
- HIV epidemic costs $14.6 trillion in economic losses by 2030 if unchecked.
- Gender inequality increases women's HIV vulnerability by 50% in high-prevalence areas.
Mortality and Socioeconomic Impact Interpretation
Prevention and Treatment
- Condom use during sex with non-regular partners reached 70% in high HIV burden countries in 2022.
- Voluntary medical male circumcision averted an estimated 3.5 million new HIV infections in 15 countries since 2010.
- PrEP use prevented 74,000 new infections globally in 2022.
- 85% of children under 15 newly infected with HIV in 2022 acquired it through mother-to-child transmission.
- Global ART coverage reached 76% for adults and 73% for children in 2022.
- Viral suppression among people on ART was 72% in adults and 62% in children globally in 2022.
- In 2022, 92% of HIV-positive pregnant women received ART to prevent transmission to their babies.
- HIV testing services reached 86% of people living with HIV globally in 2022.
- Needle-syringe programmes provided 12 billion clean syringes in low- and middle-income countries in 2022.
- Opioid substitution therapy reached 580,000 people who inject drugs in 2022.
- Dolutegravir-based regimens were used by 75% of people on first-line ART in low- and middle-income countries by 2022.
- In the US, 66% of people living with diagnosed HIV were virally suppressed in 2021.
- Globally, 82% of people living with HIV knew their status in 2023.
- 77% of people living with HIV were on ART in 2023 globally.
- 72% of adults and 65% of children on ART had viral load suppression in 2023.
- 91% of pregnant women living with HIV accessed ART in 2023.
- PrEP initiations reached 1.3 million globally in 2023.
- Male circumcision coverage for HIV prevention was 52% in priority countries.
- Condom use with clients among female sex workers averaged 89% in 2023 surveys.
- Needle programmes distributed services to 50% of people who inject drugs needing them.
- 93% of infants exposed to HIV through mother-to-child received testing within 2 months.
- Dolutegravir first-line ART use exceeded 80% in low/middle-income countries.
- In the US, 64.4% of diagnosed PLHIV were virally suppressed in 2022.
Prevention and Treatment Interpretation
Regional Statistics
- In 2022, 1.5 million people in Eastern and Southern Africa were living with HIV, the highest regional burden.
- Western and Central Africa had 5.1 million people living with HIV in 2022.
- In Asia and the Pacific, 6.7 million people were living with HIV in 2022.
- Western and Central Europe and North America reported 2.3 million people living with HIV in 2022.
- Latin America had 2.4 million people living with HIV in 2022.
- In Eastern Europe and Central Asia, 1.8 million people were living with HIV in 2022, up 10% since 2010.
- Middle East and North Africa had 390,000 people living with HIV in 2022.
- In 2022, Eastern and Southern Africa accounted for 20.8% of global new HIV infections with 650,000 cases.
- South Africa had the largest number of people living with HIV at 7.8 million in 2022.
- Nigeria reported 1.9 million people living with HIV in 2022.
- In the United States, 1.2 million people were living with HIV in 2021.
- In sub-Saharan Africa, 25.6 million people were living with HIV in 2022, representing 65% of the global total.
- In 2022, Eastern Europe saw a 10% increase in new HIV infections to 170,000.
- Caribbean region had 320,000 people living with HIV in 2022.
- In Western Africa, new HIV infections declined by 37% since 2010 to 190,000 in 2022.
- Eastern and Southern Africa: 20.6 million people living with HIV in 2023.
- Western and Central Africa: 5.1 million people living with HIV in 2023.
- Asia and Pacific: 6.8 million people living with HIV in 2023.
- Western/Central Europe & North America: 2.3 million people living with HIV in 2023.
- Eastern Europe & Central Asia: 2.0 million people living with HIV in 2023.
- Latin America: 2.5 million people living with HIV in 2023.
- Caribbean: 330,000 people living with HIV in 2023.
- Middle East & North Africa: 400,000 people living with HIV in 2023.
- In South Africa, 7.8 million adults aged 15-49 were living with HIV in 2023, prevalence 19%.
- Nigeria had 2.0 million people living with HIV in 2023.
- In the US, new HIV diagnoses were 31,800 in 2022.
- Mozambique reported HIV prevalence of 11% among adults in 2023.
- Eswatini had the highest adult HIV prevalence at 27% in 2023.
Regional Statistics Interpretation
Transmission Methods
- Heterosexual transmission accounted for 72% of new HIV infections among adults in 2022 globally.
- In Eastern and Southern Africa, 80% of new infections were through sex between men and women in 2022.
- Sex between men accounted for 21% of new HIV infections globally in 2022.
- People who inject drugs contributed to 11% of new global HIV infections in 2022.
- Mother-to-child transmission has declined 62% since 2010, with 83% prevention coverage in 2022.
- In the US, 68% of new HIV transmissions in 2021 were attributed to male-to-male sexual contact.
- Globally, only 65% of people living with HIV had viral suppression in 2022.
- Sharing needles and syringes among people who inject drugs causes 10% of new HIV infections worldwide.
- In Eastern Europe, 55% of new HIV infections in 2022 were among people who inject drugs.
- Unsafe medical injections account for less than 0.1% of new HIV infections globally due to prevention efforts.
- Sex between men caused 30% of new infections outside sub-Saharan Africa in 2023.
- Heterosexual sex accounted for 64% of new global HIV infections in 2023.
- In Eastern Europe, 50% of new infections were among people who inject drugs in 2023.
- Mother-to-child transmission rate reduced to 9% with ART prophylaxis.
- In the US, heterosexual contact caused 21% of new HIV diagnoses in 2022.
- Injection drug use accounted for 7% of new US HIV diagnoses in 2022.
- Globally, undiagnosed HIV cases drive 30% of new transmissions.
- Viral suppression prevents 99% of sexual transmissions per act.
- TB/HIV co-infection leads to 1 in 3 AIDS deaths.






